Capangpangan, Joel .

HRN: 28-93-04  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2026
CO-AMOXICLAV 625MG (TAB)
04/29/2026
05/06/2026
PO
625 Mg
TID
Fracture, Closed, Complete, Displaced Middle 3rd Femur, Right
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: